Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Payoneer Global Inc (PAYO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Payoneer Global IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Payoneer Global Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Payoneer Global Inc trades at $7.13 (market cap $2.42B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Payoneer Global Inc is the larger of the two by market cap, and Payoneer Global Inc is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Payoneer Global Inc for 62 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PAYOVIR
Market Cap
$2.42B$1.76B
Volume
1,987,3072,764,948
Sector
TechnologyHealth
52-Week High
$7.18$11.78
52-Week Low
$4.27$5.12
Typical Hold Time
62 Days0 Days
Enterprise Value
$2.16B$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Payoneer Global Inc

Payoneer Global (PAYO) trades at $7.15, up 0.42% with mixed technical signals showing a bullish overall trend but bearish moving averages. The company reported Q2 2026 earnings of $0.02 per share, missing estimates, while revenue grew 10% excluding interest. Recent developments include the renewal of its Etsy partnership through 2029 and the announcement of a pending acquisition by Nuvei, creating significant investor interest and legal scrutiny.

The outlook remains cautiously optimistic with 60% analyst buy ratings, though earnings volatility and the pending acquisition create uncertainty. Key opportunities include strong B2B growth acceleration (48% YoY) and expanding international presence, while risks involve integration challenges with Nuvei and margin compression as net income margins decline from 16.8% in 2024 to 5.82% projected for 2026.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PAYO
76% Buy24% Sell
Avg holding period · 62 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Payoneer Global Inc

Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.

Read more on PAYO →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →